1 study found for:    NCT01527149
Show Display Options
Rank Status Study
1 Recruiting Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Conditions: Stage I Mantle Cell Lymphoma;   Stage II Contiguous Mantle Cell Lymphoma;   Stage II Non-Contiguous Mantle Cell Lymphoma;   Stage III Mantle Cell Lymphoma;   Stage IV Mantle Cell Lymphoma
Interventions: Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dexamethasone;   Drug: Doxorubicin Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Methotrexate;   Biological: Ofatumumab;   Drug: Vincristine Sulfate

Indicates status has not been verified in more than two years